Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovel 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasting Conditions
COMPARATIVE FASTING BIOAVAILABILITY OF 2 DIFFERENT BETAHISTINE DIHYDROCHLORIDE 24-MG TABLETS: A SINGLE-DOSE, RANDOMIZED-SEQUENCE, OPEN-LABEL, 2-PERIOD CROSSOVER STUDY IN HEALTHY THAI VOLUNTEERS